Key Pharmacologic Principles and Drug-Drug Interactions in HIV Patient Care

  • Authors: Amanda H. Corbett, PharmD, BCPS, FCCP; Colin I. Sheffield, PharmD (More Info)
  • Section Editor: Eric S. Daar, MD
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 6/3/19 (What's New)

Summary

  • Coadministration of azole antifungals and antiretrovirals results in significant drug interactions (Table 5)
  • Caution should also be used if administering antiretrovirals with echinocandin antifungals caspofungin and micafungin[FDA Micafungin; FDA Caspofungin]
    • Fluconazole and NNRTIs and PIs
    • Fluconazole has least potential for drug interactions with antiretrovirals of azole antifungals with no significant effect observed or expected in combination with most boosted PIs
      Isavuconazole and NNRTIs and PIs
        Itraconazole and NNRTIs and PIs
          Posaconazole and NNRTIs and PIs
            Voriconazole and NNRTIs and PIs
              Ketoconazole and NNRTIs and PIs
                Azole Antifungals and Other Antiretrovirals

                Action required

                Keywords: Drug-Drug Interactions, Pharmacokinetics

                ©2018 Clinical Care Options, LLC. All Rights Reserved.

                The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.